Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 16 (6) , 423-424
- https://doi.org/10.1007/bf00568204
Abstract
Summary ST 1059, the pharmacologically active metabolite of midodrine, is a powerful vasoconstrictor compound, acting by stimulation of alpha-receptors. It elicited 80% of noradrenaline-induced contraction of human veins.Keywords
This publication has 5 references indexed in Scilit:
- PHYSIOLOGICAL AND PHARMACOLOGICAL STUDIES ON ISOLATED HUMAN BRONCHIAL PREPARATIONS1978
- Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059.1976
- Pathophysiological Classification and Diagnosis of Orthostatic HypotensionCardiology, 1976
- [Treatment of hypotensive circular dysregulation using Gutron in practice].1975
- [The pharmacological properties of Midodrin and its clinical application in patients with hypotensive circulatory disturbance (author's transl)].1974